CSIMarket
 


Quest Patent Research Corp  (QPRC)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

QPRC's Revenue Growth by Quarter and Year

Quest Patent Research's Revenue results by quarter and year




QPRC Revenue (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - 2.12 - -
III Quarter September - 0.64 0.01 0.58
II Quarter June - 1.01 6.21 0.64
I Quarter March 0.87 0.37 0.86 0.02
FY   0.87 4.14 7.08 1.24



QPRC Revenue first quarter 2020 Y/Y Growth Comment
Quest Patent Research Corp achieved in the first quarter, above Company average Revenue surge of 135.16% year on year, to $ 0.87 millions.

Looking into first quarter results within Biotechnology & Drugs industry 17 other companies have achieved higher Revenue growth. While Quest Patent Research Corp' s Revenue doubling of 135.16% ranks overall at the positon no. 178 in the first quarter.




QPRC Revenue ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - 6300 % -98.28 % -18.31 %
II Quarter June - -83.74 % 870.31 % 93.94 %
I Quarter March 135.16 % -56.98 % 4200 % -87.5 %
FY   - -41.53 % 470.97 % -2.36 %

Financial Statements
Quest Patent Research's first quarter 2020 Revenue $ 0.87 millions QPRC's Income Statement
Quest Patent Research's first quarter 2019 Revenue $ 0.37 millions Quarterly QPRC's Income Statement
New: More QPRC's historic Revenue Growth >>


QPRC Revenue (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - 231.25 % - -
III Quarter September - -36.63 % -99.84 % -9.38 %
II Quarter June - 172.97 % 622.09 % 3100 %
I Quarter March -58.96 % - - -71.43 %
FY (Year on Year)   - -41.53 % 470.97 % -2.36 %




Revenue first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #18
Healthcare Sector #72
Overall #178

Revenue Y/Y Growth Statistics
High Average Low
269.61 % 33.84 % -78.84 %
(March 31, 2014)   (Jun 30 2019)
Revenue first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #18
Healthcare Sector #72
Overall #178
Revenue Y/Y Growth Statistics
High Average Low
269.61 % 33.84 % -78.84 %
(March 31, 2014)   (Jun 30 2019)

Revenue by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Quest Patent Research's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
37486400.03 % 1340230.96 % -99.98 %
(Mar 31 2019)  


QPRC's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2020 Quest Patent Research Corp realized fall in Revenue sequentially by -58.96% to $ 0.87 millions, from $ 2.12 millions achived a quarter before.

Within Biotechnology & Drugs industry 62 other companies have achieved higher Revenue quarter on quarter growth. While Quest Patent Research's Revenue growth quarter on quarter, overall rank is 2493.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #63
Healthcare Sector #353
Overall #2493
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #63
Healthcare Sector #353
Overall #2493
Revenue Q/Q Growth Statistics
High Average Low
37486400.03 % 1340230.96 % -99.98 %
(Mar 31 2019)  


QPRC's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2020 Quest Patent Research Corp disclosed fall in Revenue sequentially by -58.96% to $ 0.87 millions, from $ 2.12 millions released in the previous reporting period.

Within Biotechnology & Drugs industry 62 other companies have achieved higher Revenue quarter on quarter growth. While Quest Patent Research's Revenue growth quarter on quarter, overall rank is 2493.


Quest Patent Research's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
Cumulative Revenue 12 Months Ending $ 4.64 $ 4.14 $ 2.03 $ 1.39 $ 6.59
Y / Y Revenue Growth (TTM) -29.58 % -41.39 % -71.33 % -81.77 % 217.71 %
Year on Year Revenue Growth Overall Ranking # 2334 # 3213 # 2636 # 3585 # 98
Seqeuential Revenue Change (TTM) 11.95 % 104.33 % 45.49 % -78.84 % -6.82 %
Seq. Revenue Growth (TTM) Overall Ranking # 178 # 99 # 96 # 3811 # 268




Cumulative Revenue growth Comment
Quest Patent Research showed decline, but improvement compare to trailing twelve month Revenue decrease in Dec 31 2019. If the fiscal year would end in Mar 31 2020, Quest Patent Research's annual Revenue decline would be -29.58% year on year to $5 millions.

In the Healthcare sector 291 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2334, from total ranking in previous quarter at 3213.

Revenue TTM Q/Q Growth Statistics
High Average Low
269.61 %
33.84 %
-78.84 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 18
Healthcare Sector # 292
Overall # 2334

Revenue TTM Y/Y Growth Statistics
High Average Low
1161.68 %
129.19 %
-81.77 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 18
Sector # 72
S&P 500 # 178
Cumulative Revenue growth Comment
Quest Patent Research showed decline, but improvement compare to trailing twelve month Revenue decrease in Dec 31 2019. If the fiscal year would end in Mar 31 2020, Quest Patent Research's annual Revenue drop would be -29.58% year on year to $5 millions.

In the Healthcare sector 291 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2334, from total ranking in previous quarter at 3213.

Revenue TTM Q/Q Growth Statistics
High Average Low
269.61 %
33.84 %
-78.84 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 18
Healthcare Sector # 292
Overall # 2334

Revenue TTM Y/Y Growth Statistics
High Average Low
1161.68 %
129.19 %
-81.77 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 18
Sector # 72
S&P 500 # 178




Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
QPRC's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for QPRC's Competitors
Revenue Growth for Quest Patent Research's Suppliers
Revenue Growth for QPRC's Customers

You may also want to know
QPRC's Annual Growth Rates QPRC's Profitability Ratios QPRC's Asset Turnover Ratio QPRC's Dividend Growth
QPRC's Roe QPRC's Valuation Ratios QPRC's Financial Strength Ratios QPRC's Dividend Payout Ratio
QPRC's Roa QPRC's Inventory Turnover Ratio QPRC's Growth Rates QPRC's Dividend Comparisons



Companies with similar Revenue drop for the quarter ending Mar 31 2020 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2020
Coherus Biosciences inc   213.17 %$ 213.171 millions
Therapeuticsmd Inc   210.41 %$ 210.406 millions
Harpoon Therapeutics Inc   210.16 %$ 210.160 millions
Gw Pharmaceuticals Plc  207.37 %$ 207.369 millions
Zyla Life Sciences  204.52 %$ 204.520 millions
Verastem Inc   202.57 %$ 202.573 millions
Alnylam Pharmaceuticals Inc   198.78 %$ 198.781 millions
Adma Biologics Inc   189.06 %$ 189.060 millions
Agios Pharmaceuticals Inc   188.15 %$ 188.146 millions
Healthlynked Corp  187.52 %$ 187.520 millions
Editas Medicine inc   176.61 %$ 176.607 millions
Checkpoint Therapeutics Inc   176.14 %$ 176.136 millions
Albireo Pharma Inc   171.75 %$ 171.754 millions
Venus Concept Inc   168.97 %$ 168.966 millions
Surface Oncology Inc   167.37 %$ 167.369 millions
Aethlon Medical Inc  158.41 %$ 158.411 millions
Inspiremd Inc   149.16 %$ 149.157 millions
Cue Biopharma Inc   143.24 %$ 143.243 millions
Seneca Biopharma Inc   140.80 %$ 140.800 millions
Catalyst Pharmaceuticals Inc   134.06 %$ 134.057 millions
Protagonist Therapeutics Inc   133.78 %$ 133.782 millions
Quest Patent Research Corp  132.11 %$ 132.111 millions
Unum Therapeutics Inc   130.30 %$ 130.298 millions
Arbutus Biopharma Corp  119.59 %$ 119.588 millions
Homology Medicines Inc   117.78 %$ 117.778 millions
Momenta Pharmaceuticals inc   116.12 %$ 116.120 millions
Exact Sciences Corporation  114.65 %$ 114.647 millions
Sintx Technologies Inc   113.40 %$ 113.402 millions
Hartman Vreit Xxi Inc   113.00 %$ 113.005 millions
Amarin Corp Plcuk  111.51 %$ 111.514 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GRPR's Profile

Stock Price

GRPR's Financials

Business Description

Fundamentals

Charts & Quotes

GRPR's News

Suppliers

GRPR's Competitors

Customers & Markets

Economic Indicators

GRPR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071